After over 4 years of collaborating with NASA GeneLab to build our AI technology, we are revolutionizing drug target discovery by combining AI and Space Biotech to bring fast, cost-effective, and accurate insights.

Our Bio-Discovery AI platform, Yotta, integrates multi-omic data to accurately model complex biological systems to find the most important disease targets and pathways.

We streamline target discovery, biomarker development, and mechanism of action to develop superior drugs, treatments, and diagnostic tools.

ISS

Space Biotech

Space biotechnology represents a groundbreaking frontier where life sciences and space research converge to accelerate advancements in human health. At Deep Space Biology, we harness the unique conditions of microgravity to uncover new biological insights and drive innovation forward in science.

Explainable AI

Explainable AI (XAI) is transforming how we understand and apply artificial intelligence. At Deep Space Biology, our Yotta platform is built on XAI principles to ensure that the AI insights we generate are interpretable, reliable, and actionable. By demystifying complex models and making their decisions understandable, bridging the gap between cutting-edge technology and real-world impact.

Multi-Omics

By integrating multi-omic data from both space and Earth, we construct precise models of biological systems, enabling comprehensive insights into complex interactions and accelerating scientific breakthroughs.